{"count": 13, "results": [{"_id": "39425002", "pmid": 39425002, "title": "Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling.", "journal": "Nat Metab", "authors": ["Zhang X", "Chen Y", "Sun G", "Fei Y", "Zhu H", "Liu Y", "Dan J", "Li C", "Cao X", "Liu J"], "date": "2024-10-18T00:00:00Z", "doi": "10.1038/s42255-024-01149-x", "meta_date_publication": "2024 Oct 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50240.625, "text_hl": "Mechanistically, @CHEMICAL_farnesyl_pyrophosphate @CHEMICAL_MESH:C004808 @@@FPP@@@-dependent @GENE_RHOA @GENE_387 @@@RhoA@@@ geranylgeranylation promotes @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@mitochondrial@@@ fusion and oxidative respiration through @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@mitochondrial@@@ @GENE_RHOA @GENE_387 @@@RhoA@@@-MFN interaction, which subsequently facilitates the resolution of endoplasmic reticulum stress in @GENE_CXCL9 @GENE_4283 @@@mig@@@-DCs. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, a chemical inhibitor of the @CHEMICAL_Mevalonic_Acid @CHEMICAL_MESH:D008798 @@@mevalonate@@@ pathway, restores @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@mitochondrial@@@ function in @GENE_CXCL9 @GENE_4283 @@@mig@@@-DCs and ameliorates systemic pathogenesis in @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@SLE@@@ @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Zhang X, Chen Y, Sun G, Fei Y, Zhu H, Liu Y, Dan J, Li C, Cao X, Liu J. Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling. Nat Metab. 2024 Oct 18;():. PMID: 39425002", "BibTeX": "@article{39425002, title={Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling.}, author={Zhang X and Chen Y and Sun G and Fei Y and Zhu H and Liu Y and Dan J and Li C and Cao X and Liu J}, journal={Nat Metab}}"}}, {"_id": "9759786", "pmid": 9759786, "title": "Lupus-like syndrome associated with simvastatin.", "journal": "Lancet", "authors": ["Hanson J", "Bossingham D"], "date": "1998-09-26T00:00:00Z", "doi": "10.1016/S0140-6736(05)60116-X", "meta_date_publication": "1998 Sep 26", "meta_volume": "352", "meta_issue": "9133", "meta_pages": "1070", "score": 50083.324, "text_hl": "@<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@Lupus-like syndrome@@@ associated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Hanson J, Bossingham D. Lupus-like syndrome associated with simvastatin. Lancet. 1998 Sep 26;352(9133):1070. PMID: 9759786", "BibTeX": "@article{9759786, title={Lupus-like syndrome associated with simvastatin.}, author={Hanson J and Bossingham D}, journal={Lancet}, volume={352}, number={9133}, pages={1070}}"}}, {"_id": "9743064", "pmid": 9743064, "title": "Simvastatin-induced lupus erythematosus.", "journal": "South Med J", "authors": ["Khosla R", "Butman AN", "Hammer DF"], "date": "1998-09-01T00:00:00Z", "doi": "10.1097/00007611-199809000-00016", "meta_date_publication": "1998 Sep", "meta_volume": "91", "meta_issue": "9", "meta_pages": "873-4", "score": 50082.918, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@-induced @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus erythematosus@@@.", "citations": {"NLM": "Khosla R, Butman AN, Hammer DF. Simvastatin-induced lupus erythematosus. South Med J. 1998 Sep;91(9):873-4. PMID: 9743064", "BibTeX": "@article{9743064, title={Simvastatin-induced lupus erythematosus.}, author={Khosla R and Butman AN and Hammer DF}, journal={South Med J}, volume={91}, number={9}, pages={873-4}}"}}, {"_id": "10628262", "pmid": 10628262, "title": "Simvastatin-induced lupus-like syndrome.", "journal": "Tenn Med", "authors": ["Ahmad A", "Fletcher MT", "Roy TM"], "date": "2000-01-01T00:00:00Z", "meta_date_publication": "2000 Jan", "meta_volume": "93", "meta_issue": "1", "meta_pages": "21-2", "score": 50082.906, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@-induced @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus-like syndrome@@@.", "citations": {"NLM": "Ahmad A, Fletcher MT, Roy TM. Simvastatin-induced lupus-like syndrome. Tenn Med. 2000 Jan;93(1):21-2. PMID: 10628262", "BibTeX": "@article{10628262, title={Simvastatin-induced lupus-like syndrome.}, author={Ahmad A and Fletcher MT and Roy TM}, journal={Tenn Med}, volume={93}, number={1}, pages={21-2}}"}}, {"_id": "15118389", "pmid": 15118389, "title": "Lupus-like syndrome associated with statin therapy.", "journal": "Dermatology", "authors": ["Noël B", "Panizzon RG"], "date": "2004-01-01T00:00:00Z", "doi": "10.1159/000077320", "meta_date_publication": "2004", "meta_volume": "208", "meta_issue": "3", "meta_pages": "276-7", "score": 50060.598, "text_hl": "@<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@Lupus-like syndrome@@@ associated with statin therapy.", "citations": {"NLM": "Noël B, Panizzon RG. Lupus-like syndrome associated with statin therapy. Dermatology. 2004;208(3):276-7. PMID: 15118389", "BibTeX": "@article{15118389, title={Lupus-like syndrome associated with statin therapy.}, author={Noël B and Panizzon RG}, journal={Dermatology}, volume={208}, number={3}, pages={276-7}}"}}, {"_id": "29699441", "pmid": 29699441, "title": "Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study.", "journal": "Lupus", "authors": ["Kotyla PJ"], "date": "2018-08-01T00:00:00Z", "doi": "10.1177/0961203318772015", "meta_date_publication": "2018 Aug", "meta_volume": "27", "meta_issue": "9", "meta_pages": "1572-1573", "score": 50060.055, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ reduces @DISEASE_Antiphospholipid_Syndrome @DISEASE_MESH:D016736 @@@antiphospholipid antibodies@@@ formation in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@systemic lupus erythematosus@@@: a preliminary study.", "citations": {"NLM": "Kotyla PJ. Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study. Lupus. 2018 Aug;27(9):1572-1573. PMID: 29699441", "BibTeX": "@article{29699441, title={Simvastatin reduces antiphospholipid antibodies formation in patients with systemic lupus erythematosus: a preliminary study.}, author={Kotyla PJ}, journal={Lupus}, volume={27}, number={9}, pages={1572-1573}}"}}, {"_id": "12671581", "pmid": 12671581, "title": "[Simvastatin-induced lichen planus pemphigoides].", "journal": "Ann Dermatol Venereol", "authors": ["Stoebner PE", "Michot C", "Ligeron C", "Durand L", "Meynadier J", "Meunier L"], "date": "2003-02-01T00:00:00Z", "meta_date_publication": "2003 Feb", "meta_volume": "130", "meta_issue": "2 Pt 1", "meta_pages": "187-90", "score": 50060.01, "text_hl": "[@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@-induced @DISEASE_Lichen_Planus @DISEASE_MESH:D008010 @@@lichen planus pemphigoides@@@].", "citations": {"NLM": "Stoebner PE, Michot C, Ligeron C, Durand L, Meynadier J, Meunier L. [Simvastatin-induced lichen planus pemphigoides]. Ann Dermatol Venereol. 2003 Feb;130(2 Pt 1):187-90. PMID: 12671581", "BibTeX": "@article{12671581, title={[Simvastatin-induced lichen planus pemphigoides].}, author={Stoebner PE and Michot C and Ligeron C and Durand L and Meynadier J and Meunier L}, journal={Ann Dermatol Venereol}, volume={130}, number={2 Pt 1}, pages={187-90}}"}}, {"_id": "29600937", "pmid": 29600937, "title": "Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus.", "journal": "Clin Exp Rheumatol", "authors": ["Kotyla PJ"], "date": "2019-11-01T00:00:00Z", "meta_date_publication": "2019 Nov-Dec", "meta_volume": "37 Suppl 122", "meta_issue": "6", "meta_pages": "6-7", "score": 50060.008, "text_hl": "Low dose of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ reduces disease activity and improves endothelial function in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@systemic lupus erythematosus@@@.", "citations": {"NLM": "Kotyla PJ. Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 122(6):6-7. PMID: 29600937", "BibTeX": "@article{29600937, title={Low dose of simvastatin reduces disease activity and improves endothelial function in patients with systemic lupus erythematosus.}, author={Kotyla PJ}, journal={Clin Exp Rheumatol}, volume={37 Suppl 122}, number={6}, pages={6-7}}"}}, {"_id": "16920939", "pmid": 16920939, "title": "Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.", "journal": "J Immunol", "authors": ["Aprahamian T", "Bonegio R", "Rizzo J", "Perlman H", "Lefer DJ", "Rifkin IR", "Walsh K"], "date": "2006-09-01T00:00:00Z", "doi": "10.4049/jimmunol.177.5.3028", "meta_date_publication": "2006 Sep 1", "meta_volume": "177", "meta_issue": "5", "meta_pages": "3028-34", "score": 50056.484, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment ameliorates @DISEASE_Autoimmune_Diseases @DISEASE_MESH:D001327 @@@autoimmune disease@@@ associated with accelerated @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@ in a @SPECIES_10090 @@@murine@@@ @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@ model.", "citations": {"NLM": "Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, Walsh K. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol. 2006 Sep 1;177(5):3028-34. PMID: 16920939", "BibTeX": "@article{16920939, title={Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.}, author={Aprahamian T and Bonegio R and Rizzo J and Perlman H and Lefer DJ and Rifkin IR and Walsh K}, journal={J Immunol}, volume={177}, number={5}, pages={3028-34}}"}}, {"_id": "12945719", "pmid": 12945719, "title": "Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.", "journal": "Lupus", "authors": ["Abud-Mendoza C", "de la Fuente H", "Cuevas-Orta E", "Baranda L", "Cruz-Rizo J", "González-Amaro R"], "date": "2003-01-01T00:00:00Z", "doi": "10.1191/0961203303lu429oa", "meta_date_publication": "2003", "meta_volume": "12", "meta_issue": "8", "meta_pages": "607-11", "score": 50052.05, "text_hl": "A significant reduction in spontaneous apoptosis of peripheral blood lymphocytes and expression of @GENE_CD69 @GENE_969 @@@CD69@@@ and HLA-DR was observed in @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@SLE@@@ @SPECIES_9606 @@@patients@@@ after @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ therapy. ", "citations": {"NLM": "Abud-Mendoza C, de la Fuente H, Cuevas-Orta E, Baranda L, Cruz-Rizo J, González-Amaro R. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. Lupus. 2003;12(8):607-11. PMID: 12945719", "BibTeX": "@article{12945719, title={Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.}, author={Abud-Mendoza C and de la Fuente H and Cuevas-Orta E and Baranda L and Cruz-Rizo J and González-Amaro R}, journal={Lupus}, volume={12}, number={8}, pages={607-11}}"}}]}